Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus Synvisc for mild to moderate knee osteoarthritis
ACTRN12611000651987Phase 3Completed
- Sponsor
- Kade Paterson
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) and osteochondral defect (OCD) comparing Platelet-rich plasma with Synvisc comparator (2 arms). Primary endpoints: Pain and Knee Injury and Osteoarthritis Outcome Score. Started Jul 2011; status: completed.
02
Drugs
platelet-rich plasmasodium hyaluronate
03
Conditions
osteoarthritis (OA)osteochondral defect (OCD)
Beyond the preview
Go deeper on ACTRN12611000651987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000651987.